Stocks Health care BTCY
OTC · Health careBiotricity Inc. (BTCY)
Biotricity Inc. brought in $16.4M of revenue over the twelve months to June 30, 2026, up 13.4% from a year earlier. It posted a net loss of $2.7M. At June 30, 2026 it held $466.5K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.
Watch BTCY in 60 secondsWhat Biotricity Inc. does
Biotricity Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker BTCY.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $16M | -$2.4M | -$0.12 | n/a |
| 2025 | $13.8M | -$8.4M | -$0.56 | n/a |
| 2024 | $12.1M | -$14.1M | -$1.66 | n/a |
| 2023 | $9.6M | -$18.7M | -$2.26 | n/a |
| 2022 | $7.7M | -$29.1M | -$3.99 | -$15.2M |
| 2021 | $3.4M | -$15.5M | -$2.63 | n/a |
Full financial statements: income, balance sheet and cash flow
Where BTCY ranks in Health care
Dividends
It paid out $603K in cash dividends.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2021 | n/a | $603K | n/a |
| 2020 | n/a | $180K | n/a |
Latest SEC filings
What Biotricity Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 19, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 10% to $4.3M versus the same quarter last year; diluted EPS -$0.05 versus -$0.03.
- August 17, 2026Late quarterly report notice NT 10-Q
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- July 14, 2026Annual report 10-K · period to March 31, 2026Revenue rose 16% to $16M versus the prior year; diluted EPS -$0.12 versus -$0.56.
- June 29, 2026Late annual report notice NT 10-K
- June 16, 2026Form DEF 14C filing DEF 14C
- May 29, 2026Form PRE 14C filing PRE 14C
- May 12, 2026Passive stake changed SCHEDULE 13G/A
- May 1, 2026
- February 18, 2026
Who owns BTCY
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Ionic Ventures, LLC13G, passive with 3 related filers | 9.9% | August 14, 2026 |
Largest institutional holders
Insiders
Questions about BTCY
What does Biotricity Inc. do?
Biotricity Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker BTCY.
Is Biotricity Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $2.7M on revenue of $16.4M.
How much revenue does Biotricity Inc. make?
Over the twelve months to June 30, 2026 Biotricity Inc. reported revenue of $16.4M. That is 13.4% more than a year earlier.
When did Biotricity Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026.
Similar companies
Compare BTCY with
Follow BTCY
Get an email when Biotricity Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BTCY: get an email when it filesWhere the numbers come from
Financial figures are the values Biotricity Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.